Synergistic cytotoxicity from nitric oxide and hyperoxia in cultured lung cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 274, Issue 3 18-3, 1998, Pages

  Narula, Pramod ^a   Xu, Jing ^a   Kazzaz, Jeffrey A ^a   Robbins, Carolyn G ^a   Davis, Jonathan M ^a   Horowitz, Stuart ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Apoptosis; Lung injury; Oxygen toxicity; Persistent pulmonary hypertension of the newborn

Indexed keywords

2,2' (HYDROXYNITROSOHYDRAZONO) BIS ETHANAMINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; OXYGEN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HYPEROXIA; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; NEWBORN DISEASE; OXYGEN THERAPY; OXYGEN TOXICITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0031942961     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1998.274.3.l411     Document Type: Article

References (24)

1. Abman, S. H., B. A. Chatfield, S. L. Hall, and I. F. McMurtry. Role of EDRF during transition of pulmonary circulation at birth. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H1921-H1927, 1990.
2. Albrecht, H., J. Tschopp, and C. V. Jongeneel. Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-kappa B by TNF. FEBS Lett. 351: 45-48, 1994.
3. Beckman, J. S., T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624, 1990.
4. Cappelletti, G., C. Incani, and R. Maci. Paraquat induces irreversible actin cytoskeleton disruption in cultured human lung cells. Cell Biol. Toxicol. 10: 255-263, 1994.
5. Finer, N. N., P. C. Etches, B. Kamstra, A. J. Tierney, A. Peliowsky, and A. Ryan. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J. Pediatr. 124: 303-308, 1994.
6. Forrest, V. J., Y. H. Rang, D. E. McClain, D. H. Robinson, and N. Ramakrishnan. Oxidative stress-induced apoptosis prevented by Troxlox. Free Radic. Biol. Med. 16: 675-684, 1994.
7. Frostell, C., M. D. Fratacci, J. C. Wain, R. Jones, and W. M. Zapol. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038-2047, 1991.
8. Garat, C., C. Jayr, S. Eddahibi, M. Laffon, M. Meignan, and S. Adnot. Effects of inhaled nitric oxide or inhibition of endogenous nitric oxide formation on hyperoxic lung injury. Am. J. Respir. Crit. Care Med. 155: 1957-1964, 1997.
9. Gille, J. J. P., C. G. M. Vanberkel, and H. Joenje. Mutagenicity of metabolic oxygen radicals in mammalian cell cultures. Carcinogenesis 15: 2695-2699, 1994.
10. Haddad, I. Y., H. Ischiropoulos, B. A. Holm, J. R. Beckman, J. R. Baker, and S. Matalon. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am. J. Physiol. 265 (Lung Cell. Mol. Physiol. 9): L555-L564, 1993.
11. Hallman, M., F. Waffarn, K. Bry, R. Turbow, M. T. Kleinman, W. J. Mautz, R. E. Rasmussen, D. K. Bhalla, and R. F. Phalen. Surfactant dysfunction after inhalation of nitric oxide. J. Appl. Physiol. 80: 2026-2034, 1996.
12. Haydar, A., P. Mauriat, P. Pouard, D. Lefebvre, T. Malhere, D. Journois, N. Denis, D. Safran, and P. Vouhe. Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet 340: 818-819, 1992.
13. Ignarro, L. J., G. M. Buga, K. S. Wood, R. E. Byrns, and G. Chaudhuri. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84: 9265-9269, 1987.
14. Jia, L., C. Bonaventura, J. Bonaventura, and J. S. Stamler. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380: 221-226, 1996.
15. Kazzaz, J., J. Xu, T. Palaia, L. Mantell, A. M. Fein, and S. Horowitz. Cellular oxygen toxicity: oxidant injury without apoptosis. J. Biol. Chem. 271: 15182-15186, 1996.
16. Kinsella, J. P., S. R. Neish, D. D. Ivy, E. Shaffer, and S. H. Abman. Clinical response to prolonged treatment of persistant pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J. Pediatr. 123: 103-108, 1993.
17. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
18. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
19. Robbins, C. G., J. M. Davis, T. A. Merritt, J. Amirkhanian, N. Sahgal, F. C. Morin III, and S. Horowitz. Combined effects of nitric oxide and hyperoxia on surfactant function and pulmonary inflammation. Am. J. Physiol. 269 (Lung Cell. Mol. Physiol. 13): L545-L550, 1995.
20. Roberts, J. D., D. M. Polaner, P. Lang, and W. M. Zapol. Inhaled nitric oxide in persistant pulmonary hypertension of the newborn. Lancet 340: 818-819, 1992.
21. Sandstrom, P. A., B. Roberts, T. M. Folks, and T. M. Buttke. HIV gene expression enhances T cell susceptibility to hydrogen peroxide-induced apoptosis. AIDS Res. Hum. Retroviruses 9: 1107-1113, 1993.
22. Sellden, H., P. Winberg, L. E. Gustafsson, B. Lundell, K. Book, and C. G. Frostell. Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2-kg infant. Anesthesiology 78: 577-560, 1993.
23. Slater, A. F. G., C. S. I. Nobel, and S. Orrenius. The role of intracellular oxidants in apoptosis. Biochim. Biophys. Acta 1271: 59-62, 1995.
24. Waldman, S. A., and F. Murad. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system. J. Cardiovasc. Pharmacol. 12, Suppl. 5: S115-S118, 1988.